Publications A review of the clinical and economic outcomes of imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia
Publications Oral antiplatelet therapy in secondary prevention of cardiovascular events: an assessment from the payer’s perspective
Publications Cost-effectiveness and budget impact of long-acting risperidone in Portugal: a modeling exercise
Publications Increasing decision-makers’ access to economic evaluations: alternative methods of communicating the information
Publications A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss